Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G4375F108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Berkley W R Corp
13G/A
Amendment 3
|
0% |
8/6/2026
Event 6/30/2026
|
|
| W. R. Berkley Corporation | 0% | ||
| Berkley Insurance Company | 0% | ||
|
Fort Baker Capital Management LP
13G/A
Amendment 2
|
1.1% |
5/15/2026
Event 3/31/2026
|
|
| Fort Baker Capital Management LP | 1.1% | ||
| Steven Patrick Pigott | 1.1% | ||
| Fort Baker Capital, LLC | 1.1% | ||
|
First Trust Capital Management L.P.
13G/A
Amendment 3
|
1.1% |
5/15/2026
Event 3/31/2026
|
|
| First Trust Merger Arbitrage Fund | 1.0% | ||
| First Trust Capital Management L.P. | 1.1% | ||
| First Trust Capital Solutions L.P. | 1.1% | ||
| FTCS Sub GP LLC | 1.1% | ||
| Mizuho Financial Group, Inc. 13G/A Amendment 1 | 0% |
5/14/2026
Event 3/31/2026
|
|
|
Berkley W R Corp
13G/A
Amendment 2
|
9.9% |
5/8/2026
Event 3/31/2026
|
|
| W.R. Berkley Corporation | 9.9% | ||
| Berkley Insurance Company | 9.9% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
0% |
5/5/2026
Event 4/30/2026
|
|
| American Century Capital Portfolios, Inc. | 0% | ||
| American Century Investment Management, Inc. | 0% | ||
| American Century Companies, Inc. | 0% | ||
| Stowers Institute for Medical Research | 0% | ||
| Wasatch Advisors LP 13G/A Amendment 1 | 0% |
4/29/2026
Event 4/9/2026
|
|
| Wasatch Advisors LP 13G | 7.1% |
4/29/2026
Event 3/31/2026
|
|
|
Wolverine Asset Management, LLC
13G/A
Amendment 1
|
0% |
4/20/2026
Event 4/14/2026
|
|
| Wolverine Asset Management, LLC | 0% | ||
| Wolverine Holdings, LLC | 0% | ||
| Christopher L. Gust | 0% | ||
| Robert R. Bellick | 0% | ||
|
Harraden Circle Investments, LLC
13G/A
Amendment 3
|
0% |
4/17/2026
Event 4/8/2026
|
|
| Harraden Circle Investments, LLC | 0% | ||
| Harraden Circle Investors GP, LP | 0% | ||
| Harraden Circle Investors GP, LLC | 0% | ||
| Harraden Circle Investors, LP | 0% | ||
| Harraden Circle Special Opportunities, LP | 0% | ||
| Harraden Circle Strategic Investments, LP | 0% | ||
| Harraden Circle Concentrated, LP | 0% | ||
| Frederick V. Fortmiller, Jr. | 0% | ||
|
Haymaker Sponsor IV LLC
13D/A
Amendment 1
|
0% |
4/15/2026
Event 4/8/2026
|
|
| Haymaker Sponsor IV LLC | 0% | ||
| Andrew R. Heyer | 0% | ||
| Steven Heyer | 0% | ||
|
Wealthspring Capital LLC
13G/A
Amendment 1
|
0% |
4/9/2026
Event 3/31/2026
|
|
| Wealthspring Capital LLC | 0% | ||
| Matthew Simpson | 0% | ||
|
Harraden Circle Investments, LLC
13G/A
Amendment 2
|
20.9% |
4/8/2026
Event 4/8/2026
|
|
| Harraden Circle Investments, LLC | 20.9% | ||
| Harraden Circle Investors GP, LP | 20.9% | ||
| Harraden Circle Investors GP, LLC | 20.9% | ||
| Harraden Circle Investors, LP | 10.6% | ||
| Harraden Circle Special Opportunities, LP | 3.6% | ||
| Harraden Circle Strategic Investments, LP | 4.5% | ||
| Harraden Circle Concentrated, LP | 2.3% | ||
| Frederick V. Fortmiller, Jr. | 20.9% | ||
|
Harraden Circle Investments, LLC
13G/A
Amendment 1
|
8.7% |
4/8/2026
Event 3/31/2026
|
|
| Harraden Circle Investments, LLC | 8.7% | ||
| Harraden Circle Investors GP, LP | 8.7% | ||
| Harraden Circle Investors GP, LLC | 8.7% | ||
| Harraden Circle Investors, LP | 4.99% | ||
| Harraden Circle Special Opportunities, LP | 1.9% | ||
| Harraden Circle Strategic Investments, LP | 1.3% | ||
| Harraden Circle Concentrated, LP | 0.5% | ||
| Frederick V. Fortmiller, Jr. | 8.7% | ||
|
American Century Investment Management, Inc.
13G
|
11.6% |
4/7/2026
Event 3/31/2026
|
|
| American Century Capital Portfolios, Inc. | 7.8% | ||
| American Century Investment Management, Inc. | 11.6% | ||
| American Century Companies, Inc. | 11.6% | ||
| Stowers Institute for Medical Research | 11.6% | ||
|
Harraden Circle Investments, LLC
13G
|
10.0% |
3/11/2026
Event 3/4/2026
|
|
| Harraden Circle Investments, LLC | 10.0% | ||
| Harraden Circle Investors GP, LP | 10.0% | ||
| Harraden Circle Investors GP, LLC | 10.0% | ||
| Harraden Circle Investors, LP | 5.7% | ||
| Harraden Circle Special Opportunities, LP | 2.2% | ||
| Harraden Circle Strategic Investments, LP | 1.5% | ||
| Harraden Circle Concentrated, LP | 0.6% | ||
| Frederick V. Fortmiller, Jr. | 10.0% | ||
| Mizuho Financial Group, Inc. 13G | 5.3% |
2/12/2026
Event 12/31/2025
|
|
|
Berkley W R Corp
13G/A
Amendment 1
|
8.4% |
2/10/2026
Event 12/31/2025
|
|
| W. R. Berkley Corporation | 8.4% | ||
| Berkley Insurance Company | 8.4% | ||
|
First Trust Capital Management L.P.
13G/A
Amendment 2
|
6.3% |
11/14/2025
Event 9/30/2025
|
|
| First Trust Merger Arbitrage Fund | 5.9% | ||
| First Trust Capital Management L.P. | 6.3% | ||
| First Trust Capital Solutions L.P. | 6.3% | ||
| FTCS Sub GP LLC | 6.3% | ||
|
Westchester Capital Management, LLC
13G/A
Amendment 1
|
8.3% |
11/14/2025
Event 9/30/2025
|
|
| Westchester Capital Management, LLC | 8.3% | ||
| Westchester Capital Partners, LLC | <0.1% | ||
| Virtus Investment Advisers, LLC | 7.9% | ||
| The Merger Fund | 7.6% | ||
|
Berkley W R Corp
13G
|
7.2% |
11/10/2025
Event 9/30/2025
|
|
| W. R. Berkley Corporation | 7.2% | ||
| Berkley Insurance Company | 7.2% | ||
|
Wolverine Asset Management LLC
13G
|
6.2% |
10/10/2025
Event 9/30/2025
|
|
| Wolverine Asset Management LLC | 6.2% | ||
| Wolverine Trading Partners, Inc. | 6.2% | ||
| Wolverine Holdings, L.P. | 6.2% | ||
| Christopher L. Gust | 6.2% | ||
| Robert R. Bellick | 6.2% | ||
|
Fort Baker Capital Management LP
13G/A
Amendment 1
|
9.0% |
5/15/2025
Event 3/31/2025
|
|
| Fort Baker Capital Management LP | 9.0% | ||
| Steven Patrick Pigott | 9.0% | ||
| Fort Baker Capital, LLC | 9.0% | ||
| Westchester Capital Management, LLC 13G | 5.0% |
5/14/2025
Event 3/31/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 34 | 18.7 M | $208 M |
| 2025 Q4 | 49 | 22.2 M | $252 M |
| 2025 Q3 | 51 | 22.1 M | $250 M |
| 2025 Q2 | 61 | 22.2 M | $246 M |
| 2025 Q1 | 57 | 22.0 M | $238 M |
| 2024 Q4 | 57 | 21.6 M | $233 M |
| 2024 Q3 | 52 | 20.7 M | $221 M |
| 2024 Q2 | 62 | 20.1 M | $211 M |
| 2024 Q1 | 62 | 21.9 M | $228 M |
| 2023 Q4 | 60 | 19.3 M | $198 M |
| 2023 Q3 | 44 | 14.2 M | $144 M |